Walgreens Boots Alliance (WBA) Receives New Coverage from Analysts at Deutsche Bank

Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA) in a report issued on Monday. The brokerage issued a hold rating and a $78.00 price target on the pharmacy operator’s stock.

Several other equities research analysts have also recently commented on WBA. Pivotal Research cut their price target on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a hold rating on the stock in a research report on Tuesday, October 24th. Loop Capital began coverage on shares of Walgreens Boots Alliance in a research report on Thursday, August 24th. They set a buy rating and a $95.00 price target on the stock. Needham & Company LLC reissued a buy rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, October 12th. BidaskClub cut shares of Walgreens Boots Alliance from a hold rating to a sell rating in a research report on Tuesday, September 12th. Finally, Royal Bank Of Canada reissued a buy rating and set a $88.00 price target on shares of Walgreens Boots Alliance in a research report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have assigned a buy rating to the company. Walgreens Boots Alliance currently has a consensus rating of Buy and a consensus target price of $86.47.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) traded up $0.12 during mid-day trading on Monday, hitting $71.57. 10,287,200 shares of the stock traded hands, compared to its average volume of 5,441,608. Walgreens Boots Alliance has a one year low of $63.82 and a one year high of $88.00. The firm has a market cap of $70,760.91, a price-to-earnings ratio of 14.01, a price-to-earnings-growth ratio of 1.27 and a beta of 1.22. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.07 EPS. sell-side analysts predict that Walgreens Boots Alliance will post 5.55 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.24%. Walgreens Boots Alliance’s dividend payout ratio is 42.33%.

Walgreens Boots Alliance announced that its board has initiated a stock buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its stock is undervalued.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now owns 16,415 shares in the company, valued at $1,105,878.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director John Anthony Lederer bought 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The stock was bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.

Institutional investors have recently modified their holdings of the business. Hudock Capital Group LLC raised its stake in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 6 shares during the last quarter. Modera Wealth Management LLC raised its stake in shares of Walgreens Boots Alliance by 0.4% during the first quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock valued at $204,000 after acquiring an additional 9 shares during the last quarter. Flagship Harbor Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 0.5% during the first quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock valued at $243,000 after acquiring an additional 16 shares during the last quarter. Sowell Financial Services LLC raised its stake in shares of Walgreens Boots Alliance by 0.6% during the first quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock valued at $218,000 after acquiring an additional 17 shares during the last quarter. Finally, WealthTrust Arizona LLC raised its stake in shares of Walgreens Boots Alliance by 0.4% during the second quarter. WealthTrust Arizona LLC now owns 5,264 shares of the pharmacy operator’s stock valued at $412,000 after acquiring an additional 21 shares during the last quarter. Hedge funds and other institutional investors own 60.24% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Walgreens Boots Alliance (WBA) Receives New Coverage from Analysts at Deutsche Bank” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/05/walgreens-boots-alliance-wba-receives-new-coverage-from-analysts-at-deutsche-bank.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply